Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,028,361
-
Share change
-
+761,327
-
Total reported value
-
$674,021,995
-
Price per share
-
$51.87
-
Number of holders
-
62
-
Value change
-
+$63,512,327
-
Number of buys
-
45
-
Number of sells
-
30
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q3 2018
As of 30 Sep 2018,
AVROBIO INC - COM (AVRO) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,028,361 shares.
The largest 10 holders included
SV Health Investors, LLC, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JPMORGAN CHASE & CO, FARALLON CAPITAL MANAGEMENT LLC, EMERALD ADVISERS INC/PA, BlackRock Inc., and WELLS FARGO & COMPANY/MN.
This page lists
62
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.